What Is The Forecast Valuation Of The Global Gastric Volvulus Treatment Market Projected To Reach $37.18 Billion By 2029?
Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.
How Big Is The Gastric Volvulus Treatment Market Today And What Is Its Future Size?
In the past few years, the gastric volvulus treatment market has been expanding steadily. The market is expected to rise from $27.36 billion in 2024 to $28.86 billion in 2025, marking a compound annual growth rate (CAGR) of 5.5%. Factors such as breakthroughs in surgical methods, enhanced diagnostic technology, increased awareness and guidance, the growth of minimally invasive procedures, and medical research and studies have significantly contributed to the historical growth of this market.
Rapid escalation is anticipated in the gastric volvulus treatment market in the near future. The projection suggests that the market will develop to be a $37.18 billion industry by 2029, with an annual compound growth rate of 6.5%. A wide range of factors, such as regulatory revisions and endorsements, innovation in surgical methods, an expanding elderly population, tailor-made treatment strategies, and the use of high-tech imaging techniques, could be behind this growth during the forecast period. Noteworthy trends for this period encompass less invasive surgical procedures, early diagnosis and treatment, research advancements in treatment methods, collaborative practices in the medical field, and individualized treatment plans.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9382&type=smp
Which Key Factors Are Fueling Growth In The Gastric Volvulus Treatment Market?
The anticipated increase in the population of older adults, 65 years and above, is set to spur the development of the gastric volvulus treatment market. It’s acknowledged that this geriatric populace is prone to various diseases due to ageing and decreased immunity, including gastric volvulus, which particularly affects those over 50 years. Therefore, the expected escalation of the geriatric demographic will likely drive the market. For illustration, statistics released by the US-based Population Reference Bureau (PRB), a nonprofit institution, in January 2024 projects a shift in the number of Americans aged 65 and over from 58 million in 2022 to 82 million in 2050, being a 47% increase. Concurrently, their segment of the total population is indicated to rise from 17% to 23%. Consequently, increasing numbers of older adults could boost the gastric volvulus treatment market.
How Is The Gastric Volvulus Treatment Market Segmented Across Key Categories?
The gastric volvulus treatmentmarket covered in this report is segmented –
1) By Type: Organo-Axial Volvulus; Mesentero-Axial Volvulus
2) By Treatment Type: Medication; Surgery
3) By Route Of Administration: Oral; Parenteral
4) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy
5) By End-User: Hospitals; Homecare; Specialty Clinics; Other End-Users
Subsegments:
1) By Organo-Axial Volvulus: Surgical Intervention; Endoscopic Management; Gastropexy; Other Treatment Methods
2) By Mesentero-Axial Volvulus: Surgical Intervention; Gastropexy; Endoscopic Techniques; Other Treatment Approaches
What Future-Focused Trends Are Anticipated In The Gastric Volvulus Treatment Market?
The rise of product innovations in the gastric volvulus treatment market is a noticeable trend being endorsed by key players in the market. Major firms in the industry are stepping up their game by creating groundbreaking products to consolidate their market position. A case in point is when Pfizer Inc., a pharmaceutical enterprise based in the US, publicized in October 2023 that VELSIPITY (etrasimod) had received the stamp of approval from the U.S. Food and Drug Administration (FDA). It’s a once-daily oral sphingosine-1-phosphate (S1P) receptor activator intended for individuals with moderate to severe active ulcerative colitis (UC). The recommended dosage for VELSIPITY is 2 mg. This revolutionary medication offers adults with active UC the chance for steroid-free resolution through an oral pill taken once daily that presents a favorable benefit-risk ratio. The endorsement of VELSIPITY by the FDA represents a significant milestone for UC patients seeking new treatments for their chronic condition, paving the way for advanced therapy.
Who Are The Leading Companies Driving The Gastric Volvulus Treatment Market?
Major companies operating in the gastric volvulus treatment market include PAI Pharma, Sun Pharmaceutical Industries Ltd., ANI Pharmaceuticals Inc., Fresenius SE and Co. KGaA, Mayne Pharma Group Limited, Sawai Pharmaceutical Co.Ltd., Teva Pharmaceutical Industries Ltd., Glenmark Pharmaceuticals Ltd., Tris Pharma Inc., Pfizer Inc., Mallinckrodt Pharmaceuticals, GlaxoSmithKline plc, Endo International plc, Vintage Labs, Zydus Group, Bayer AG, AbbVie Inc., Amgen Inc., Johnson & Johnson Services Inc., UCB S.A., Novartis International AG, Merck & Co. Inc., Bristol-Myers Squibb Company, Sanofi S.A., Celltrion Inc., HanAll Biopharma, AstraZeneca plc
Access The Complete Report Here:
https://www.thebusinessresearchcompany.com/report/gastric-volvulus-treatment-global-market-report
Which Region Dominates The Gastric Volvulus Treatment Market Today?
North America was the largest region in the gastric volvulus market in 2024. Asia-Pacific is expected to be the fastest-growing region in the gastric volvulus treatment market report during the forecast period. The regions covered in the gastric volvulus treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=9382&type=smp
Browse Through More Reports Similar to the Global Gastric Volvulus Treatment Market 2025, By The Business Research Company
Wearable Blood Pressure Monitors Global Market Report 2025
Patient Blood Management Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/patient-blood-management-global-market-report
Conjugated Monoclonal Antibodie Global Market Report 2025
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
